SWS Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-35
Closed -$6.88K 138
2024
Q2
$6.88K Buy
+35
New +$7.23K ﹤0.01% 269
2020
Q3
Sell
-1,970
Closed -$327K 113
2020
Q2
$327K Buy
1,970
+210
+12% +$37.6K 0.42% 71
2020
Q1
$304K Buy
+1,760
New +$350K 0.22% 98
2019
Q3
$242K Sell
1,185
-456
-28% -$95.3K 0.14% 105
2019
Q2
$338K Buy
+1,641
New +$303K 0.21% 92
2018
Q4
$318K Buy
1,689
+21
+1% +$3.88K 0.24% 76
2018
Q3
$284K Buy
1,668
+100
+6% +$16.8K 0.18% 88
2018
Q2
$257K Buy
1,568
+909
+138% +$148K 0.18% 90
2018
Q1
$104K Buy
659
+258
+64% +$41.1K 0.08% 91
2017
Q4
$59K Buy
+401
New +$57.1K 0.04% 126

Other funds holding CME

SWS Partners's CME Position: Q3 2024 in Review

SWS Partners sold out of CME Group (CME) in Q3 2024, closing a stake of 35 shares — an estimated $6.88K sold.

SWS Partners first reported a position in CME in Q4 2017 and held it in 10 quarters. The position peaked at $338K in Q2 2019. 1,390 funds tracked by Wall St. Rank hold CME as of Q3 2024.

  • SWS Partners reported no remaining CME Group position as of Q3 2024 after selling out during the quarter.
  • SWS Partners sold 35 CME Group shares in Q3 2024, an estimated $6.88K.
  • SWS Partners first reported a position in CME Group in Q4 2017 and held it in 10 quarters.
  • SWS Partners's CME Group position peaked at $338K in Q2 2019.
  • 1,390 funds tracked by Wall St. Rank held CME Group as of Q3 2024.

Based on SWS Partners's 13F filing for Q3 2024, filed 15 Oct 2024.